83090-0008 Bortezomib

Product NDC:

83090-0008

Brand Name:

Bortezomib

Generic Name:

Bortezomib

Dosage Form Name:

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Administration Route:

Intravenous

Subcutaneous

Substances:

Name: BORTEZOMIB

Strength: 3.5

Unit: mg/3.5mL

Packages:

Code: 83090-0008-01

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (83090-008-01) / 3.5 mL in 1 VIAL, SINGLE-DOSE

Effective Date: July 15, 2023

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Proteasome Inhibitor

Minor Class:

26S

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox